Skip to content

603262.SH

技源集团

SSE · Healthcare · Medical - Pharmaceuticals · CN

CNY 18.40
+4.13%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue1.1B1.1B1.0B891.9M947.2M
Cost of Revenue618.8M628.4M566.1M506.3M579.0M
Gross Profit449.4M464.7M435.8M385.6M368.2M
Operating Expenses
R&D Expense55.5M52.5M49.7M43.0M42.4M
SG&A Expense
General & Admin Expense156.1M160.1M121.2M109.6M105.7M
Selling & Marketing Expense80.0M77.7M63.5M54.3M44.0M
Other Expenses
Total Operating Expenses306.7M295.2M236.2M206.1M196.9M
Cost and Expenses925.5M923.6M802.2M712.5M775.9M
Operating Income (EBIT)130.9M152.5M200.1M184.7M174.0M
Non-Operating
Interest Income
Interest Expense
Net Interest Income
Other Non-Op Income/Expense
Non-Operating Income (excl Interest)
EBT (Pre-Tax Income)130.0M152.5M200.1M184.7M168.3M
Income Tax Expense14.6M17.7M24.7M24.2M24.7M
Bottom Line
Net Income114.0M133.7M174.4M160.0M142.1M
Earnings from Cont. Ops115.4M134.8M175.3M160.5M143.6M
Earnings from Discont. Ops
Bottom Line Net Income114.0M133.7M174.4M160.0M142.1M
Per Share
Basic EPSCN¥0.32CN¥0.36CN¥0.50CN¥0.46CN¥0.41
Diluted EPSCN¥0.32CN¥0.36CN¥0.50CN¥0.46CN¥0.41
Revenue Per ShareCN¥2.80CN¥2.94CN¥2.87CN¥2.56CN¥2.73
Shares
Basic Shares Outstanding382.1M371.4M348.9M347.9M346.5M
Diluted Shares Outstanding382.1M371.4M348.9M347.9M346.5M
Profitability Metrics
EBITDA73.0M194.6M238.8M220.6M204.2M
D&A8.8M42.1M38.7M35.9M30.1M
EBIT

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026